Tariman, Zairen Audrey .
HRN: 23-84-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2024
CEFUROXIME 750MG (VIAL)
02/05/2024
02/11/2024
IVT
440mg
Q8hrs
ATP; PCAP B
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes